Cargando…
New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD
BACKGROUND AND OBJECTIVES: To evaluate the pathophysiology of neuromyelitis optica spectrum disorder (NMOSD) and the therapeutic mechanism and levels of interleukin-6 (IL-6) blockade (satralizumab), especially with respect to blood-brain barrier (BBB) disruption with the new in vitro and ex vivo hum...
Autores principales: | Takeshita, Yukio, Fujikawa, Susumu, Serizawa, Kenichi, Fujisawa, Miwako, Matsuo, Kinya, Nemoto, Joe, Shimizu, Fumitaka, Sano, Yasuteru, Tomizawa-Shinohara, Haruna, Miyake, Shota, Ransohoff, Richard M., Kanda, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529420/ https://www.ncbi.nlm.nih.gov/pubmed/34667128 http://dx.doi.org/10.1212/NXI.0000000000001076 |
Ejemplares similares
-
BBB building
por: Robinson, Richard
Publicado: (2008) -
When the BBB goes MIA
por: Pearson, Caroline A., et al.
Publicado: (2022) -
BBB: Permeable Conjugate of Exogenic GABA
por: Li, Qian, et al.
Publicado: (2017) -
Crosstalk between Inflammation and the BBB in Stroke
por: Huang, Yuyou, et al.
Publicado: (2020) -
Hypothalamic Leptin Resistance: From BBB to BBSome
por: López, Miguel
Publicado: (2016)